tiprankstipranks
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
US Market
CMMB
Chemomab Therapeutics
RESEARCH TOOLSreports
Want to see CMMB full AI Analyst Report?

Chemomab Therapeutics (CMMB) Stock News & Sentiment

328 Followers
Okunewitch Reiterates Buy on Emerging Nebokitug Data and Solid Cash Runway; Price Target Maintained at $5
Premium
Ratings
Okunewitch Reiterates Buy on Emerging Nebokitug Data and Solid Cash Runway; Price Target Maintained at $5
5d ago
CMMB
Chemomab Highlights New Nebokitug Data in PSC as Q1 2026 Update Underscores PSC–IBD Potential
Premium
Company Announcements
Chemomab Highlights New Nebokitug Data in PSC as Q1 2026 Update Underscores PSC–IBD Potential
11d ago
6K
CMMB
Chemomab Shareholders Approve Governance Resolutions and Capital Increase at May 5 Meeting
Premium
Company Announcements
Chemomab Shareholders Approve Governance Resolutions and Capital Increase at May 5 Meeting
18d ago
6K
CMMB
Chemomab Adjourns April 28 Shareholder Meeting to May 5 After Quorum Shortfall
Premium
Company Announcements
Chemomab Adjourns April 28 Shareholder Meeting to May 5 After Quorum Shortfall
26d ago
6K
CMMB
Chemomab Therapeutics Sets April 28, 2026 Shareholder Meeting to Vote on Capital Increase and Governance Matters
Premium
Company Announcements
Chemomab Therapeutics Sets April 28, 2026 Shareholder Meeting to Vote on Capital Increase and Governance Matters
2M ago
6K
CMMB
Chemomab Sets Single-Phase 3 Path With FDA After Strong 2025 Nebokitug Data
Premium
Company Announcements
Chemomab Sets Single-Phase 3 Path With FDA After Strong 2025 Nebokitug Data
2M ago
6K
CMMB
Chemomab Therapeutics Advances PSC Treatment with Phase 3 Trial
Premium
Company Announcements
Chemomab Therapeutics Advances PSC Treatment with Phase 3 Trial
6M ago
CMMB
More CMMB News >

CMMB News on the Web

Okunewitch Reiterates Buy on Emerging Nebokitug Data and Solid Cash Runway; Price Target Maintained at $5
TipRanks News
Bullish
Chemomab Therapeutics (CMMB) Receives a Buy from Oppenheimer
TipRanks News
Bullish
Chemomab Highlights New Nebokitug Data in PSC as Q1 2026 Update Underscores PSC–IBD Potential
TipRanks News
Neutral
Chemomab Shareholders Approve Governance Resolutions and Capital Increase at May 5 Meeting
TipRanks News
Neutral
Chemomab Adjourns April 28 Shareholder Meeting to May 5 After Quorum Shortfall
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Knight Therapeutics (OtherKHTRF) and Chemomab Therapeutics (CMMB)
TipRanks News
Bullish
Chemomab Therapeutics Sets April 28, 2026 Shareholder Meeting to Vote on Capital Increase and Governance Matters
TipRanks News
Bearish
Maxim Group Remains a Buy on Chemomab Therapeutics (CMMB)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
CMMB
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CMMB’s Media Buzz Sentiment?
1 articles about CMMB were published this week. In an average week, 1 articles are published.
    What is CMMB’s weekly average amount of articles?
    In an average week, 1 articles about CMMB are published.
      What is CMMB’s News Sentiment?
      100% of articles about CMMB were positive this week, compared to its sector average of 80%.
        Healthcare Stocks that are Trending in the News
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        TLSATiziana Life Sciences
        JUNSJupiter Neurosciences, Inc.
        IMMXImmix Biopharma
        Showing the stocks with the most bullish news sentiment over the past week